Is time to reach EDSS 6.0 faster in patients with late-onset versus young-onset multiple sclerosis?

PLoS ONE

Volumn 11, Issue 11, 2016, Pages

  Alroughani, Raed ^a,b   Akhtar, Saeed ^c   Ahmed, Samar ^d,e   Behbehani, Raed ^d   Al Hashel, Jasem ^c,d  

^a AL AMIRI HOSPITAL   (Kuwait)

^b DASMAN DIABETES INSTITUTE   (Kuwait)

^c KUWAIT UNIVERSITY   (Kuwait)

^d IBN SINA HOSPITAL   (Kuwait)

^e MINIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYCLOPHOSPHAMIDE; FINGOLIMOD; FUMARIC ACID DIMETHYL ESTER; GLATIRAMER; MITOXANTRONE; NATALIZUMAB; RITUXIMAB; TERIFLUNOMIDE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FAMILY HISTORY; GENETIC SUSCEPTIBILITY; HAZARD RATIO; HUMAN; KUWAIT; MIDDLE EAST; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PREVALENCE; RELAPSE; RISK ASSESSMENT; SPINAL CORD LESION; WHITE MATTER LESION; ADOLESCENT; COMPARATIVE STUDY; DISABILITY; FEMALE; KAPLAN MEIER METHOD; MALE; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MULTIPLE SCLEROSIS; YOUNG ADULT;

EID: 84994056535     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0165846     Document Type: Article

References (38)

1. Marrie RA, Yu N, Blanchard J., Leung S, Elliott L. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology. 2010; 74(6):465-71. doi: 10.1212/WNL.0b013e3181cf6ec0 PMID: 20071664.
2. Confavreux C, Vukusic S, Moreau T., Adeleine P. Relapses and progression of disability in multiple sclerosis. The New England journal of medicine. 2000; 343(20):1430-8. doi: 10.1056/NEJM200011163432001 PMID: 11078767.
3. Polliack ML, Barak Y, Achiron A. Late-onset multiple sclerosis. J Am Geriatr Soc. 2001; 49(2):168-71. PMID: 11207871.
4. Tremlett H, Devonshire V. Is late-onset multiple sclerosis associated with a worse outcome? Neurology. 2006; 67(6):954-9. doi: 10.1212/01.wnl.0000237475.01655.9d PMID: 17000960.
5. Delalande S, De Seze J, Ferriby D, Stojkovic T., Vermersch P. [Late onset multiple sclerosis]. Rev Neurol (Paris). 2002; 158(11):1082-7. PMID: 12451340.
6. Awad A, Stuve O. Multiple sclerosis in the elderly patient. Drugs Aging. 2010; 27(4):283-94. doi: 10. 2165/11532120-000000000-00000 PMID: 20359260.
7. Kis B, Rumberg B, Berlit P. Clinical characteristics of patients with late-onset multiple sclerosis. Journal of neurology. 2008; 255(5):697-702. doi: 10.1007/s00415-008-0778-x PMID: 18283394.
8. Al-Hashel J., Besterman AD, Wolfson C. The prevalence of multiple sclerosis in the Middle East. Neuroepidemiology. 2008; 31(2):129-37. doi: 10.1159/000151514 PMID: 18716409.
9. Alroughani R, Ahmed SF, Behbahani R, Khan R., Thussu A, Alexander KJ, et al Increasing prevalence and incidence rates of multiple sclerosis in Kuwait. Multiple sclerosis. 2014; 20(5):543-7. doi: 10.1177/1352458513504328 PMID: 24025709.
10. Polman CH, Reingold SC, Banwell B, Clanet M., Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of neurology. 2011; 69(2):292-302. doi: 10.1002/ana.22366 PMID: 21387374; PubMed Central PMCID: PMCPMC3084507.
11. Lublin FD, Reingold SC Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996; 46(4):907-11. PMID: 8780061.
12. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33(11):1444-52. PMID: 6685237.
13. Phadke JG. Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis. Brain: ajournal of neurology. 1990; 113 (Pt 6):1597-628. PMID: 2276037.
14. Noseworthy J, Paty D, Wonnacott T., Feasby T, Ebers G. Multiple sclerosis after age 50. Neurology. 1983; 33(12):1537-44. PMID: 6606140.
15. Roohani P, Emiru T, Carpenter A., Luzzio C, Freeman J, Scarberry S., et al. Late onset multiple sclerosis: Is it really late onset? Mult Scler Relat Disord. 2014; 3(4):444-9. doi: 10.1016/j.msard.2014.02.004 PMID: 25877055.
16. Arias M, Dapena D, Arias-Rivas S, Costa E., Lopez A, Prieto JM, et al Late onset multiple sclerosis. Neurologia. 2011; 26(5):291-6. doi: 10.1016/j.nrl.2010.09.008 PMID: 21163234.
17. Shirani A, Zhao Y, Petkau J., Gustafson P, Karim ME, Evans C, et al Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment. Biomed Res Int. 2015; 2015:451912. doi:10.1155/2015/451912 PMID: 25922836; PubMed Central PMCID: PMCPMC4397470.
18. Tutuncu M, Tang J, Zeid N.A., Kale N., Crusan DJ, Atkinson EJ, et al. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Multiple sclerosis. 2013; 19(2):188-98. doi: 10. 1177/1352458512451510 PMID: 22736750; PubMed Central PMCID: PMCPMC4029334.
19. Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain: a journal of neurology. 2006; 129(Pt 3):606-16. doi:10.1093/brain/awl007 PMID: 16415308.
20. Scalfari A, Lederer C, Daumer M., Nicholas R, Ebers GC, Muraro PA The relationship of age with the clinical phenotype in multiple sclerosis. Multiple sclerosis. 2016. doi: 10.1177/1352458516630396 PMID: 26869531.
21. Compston A, Coles A. Multiple sclerosis. Lancet. 2002; 359(9313):1221-31. doi:10.1016/S0140-6736(02)08220-X PMID: 11955556.
22. Leray E, Yaouanq J, Le Page E, Coustans M, Laplaud D., Oger J, et al. Evidence for a two-stage disability progression in multiple sclerosis. Brain: ajournal of neurology. 2010; 133(Pt7):1900-13. doi:10.1093/brain/awq076 PMID: 20423930; PubMed Central PMCID: PMCPMC2892936.
23. Lublin FD, Reingold SC, Cohen J.A., Cutter GR, Sorensen PS, Thompson AJ, et al Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014; 83(3):278-86. doi: 10.1212/WNL.0000000000000560 PMID: 24871874; PubMed Central PMCID: PMCPMC4117366.
24. Lorscheider J, Buzzard K, Jokubaitis V., Spelman T, Havrdova E, Horakova D., et al. Defining secondary progressive multiple sclerosis. Brain: ajournal of neurology. 2016. doi: 10.1093/brain/aww173 PMID: 27401521.
25. Etemadifar M, Abtahi SH, Minagar A, Akbari M., Masaeli A, Tabrizi N. Late-onset multiple sclerosis in Isfahan, Iran. Archives of Iranian medicine. 2012; 15(10):596-8. 0121510/AIM.004. PMID: 23020533. doi:0121510/AIM.004
26. Scalfari A, Neuhaus A, Daumer M., Ebers GC, Muraro PA. Age and disability accumulation in multiple sclerosis. Neurology. 2011; 77(13):1246-52. doi: 10.1212/WNL.0b013e318230a17d PMID: 21917763; PubMed Central PMCID: PMCPMC3179646.
27. Minden SL, Frankel D, Hadden L.S., Srinath KP, Perloff JN. Disability in elderly people with multiple sclerosis: An analysis of baseline data from the Sonya Slifka Longitudinal Multiple Sclerosis Study. NeuroRehabilitation. 2004; 19(1):55-67. PMID: 14988588.
28. Sanai SA, Saini V, Benedict R.H., Zivadinov R., Teter BE, Ramanathan M, et al. Aging and multiple sclerosis. Multiple sclerosis. 2016; 22(6):717-25. doi: 10.1177/1352458516634871 PMID: 26895718.
29. Rist JM, Franklin RJ Taking ageing into account in remyelination-based therapies for multiple sclerosis. Journal of the neurological sciences. 2008; 274(1-2):64-7. doi: 10.1016/j.jns.2008.04.027 PMID: 18539300.
30. Cossburn M, Ingram G, Hirst C., Ben-Shlomo Y, Pickersgill TP, Robertson NP Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis. Multiple sclerosis. 2012; 18(1):45-54. doi: 10.1177/1352458511417479 PMID: 21865412.
31. Nociti V, Cianfoni A, Mirabella M., Caggiula M, Frisullo G, Patanella A.K., et al. Clinical characteristics, course and prognosis of spinal multiple sclerosis. Spinal Cord. 2005; 43(12):731-4. doi: 10.1038/sj.sc3101798 PMID: 16010274.
32. Sombekke MH, Wattjes MP, Balk L.J., Nielsen JM, Vrenken H, Uitdehaag BM, et al Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology. 2013; 80(1):69-75. doi: 10.1212/WNL.0b013e31827b1a67 PMID: 23243070.
33. Patrucco L, Rojas JI, Cristiano E. Assessing the value of spinal cord lesions in predicting development of multiple sclerosis in patients with clinically isolated syndromes. Journal of neurology. 2012; 259 (7):1317-20. doi: 10.1007/s00415-011-6345-x PMID: 22179784.
34. Oh J, Saidha S, Chen M., Smith SA, Prince J, Jones C, et al Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis. Neurology. 2013; 80(6):540-7. doi: 10.1212/WNL.0b013e31828154c5 PMID: 23325903; PubMed Central PMCID: PMCPMC3589285.
35. Bernitsas E, Bao F, Seraji-Bozorgzad N, Chorostecki J., Santiago C, Tselis A, et al Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes. Mult Scler Relat Disord. 2015; 4(1):47-51. doi: 10.1016/j.msard.2014.11.002 PMID: 25787052.
36. Ribbons KA, McElduff P, Boz C., Trojano M, Izquierdo G, Duquette P., et al. Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS. PloS one. 2015; 10(6):e0122686. doi:10.1371/journal.pone.0122686 PMID: 26046348; PubMed Central PMCID: PMCPMC4457630.
37. Bove RM, Healy B, Augustine A., Musallam A, Gholipour T, Chitnis T. Effect of gender on late-onset multiple sclerosis. Multiple sclerosis. 2012; 18(10):1472-9. doi: 10.1177/1352458512438236 PMID: 22383227.
38. Shirani A, Zhao Y, Kingwell E., Rieckmann P, Tremlett H. Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009). Multiple sclerosis. 2012; 18 (4):442-50. doi: 10.1177/1352458511422097 PMID: 21952097.